Safe to Expand Limits of Active Surveillance in Thyroid Cancer?

New research shows extending active surveillance limits for tumor sizes up to 2 cm showed no increases in adverse outcomes or mortality, but ‘the expanded parameters are quite controversial.’
Medscape Medical News